Serum creatinine to cystatin C ratio reflects preoperative and early postoperative walking ability in older patients with hip fracture.

Cystatin C Functional outcome Hip fracture Sarcopenia Sarcopenia index Walking ability

Journal

Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883

Informations de publication

Date de publication:
04 2022
Historique:
revised: 09 01 2022
received: 07 07 2021
accepted: 17 01 2022
pubmed: 17 2 2022
medline: 6 4 2022
entrez: 16 2 2022
Statut: ppublish

Résumé

The sarcopenia index (SI), calculated as the ratio of serum creatinine to cystatin C levels, reflects skeletal muscle mass and strength. Patients with hip fracture (HF) and sarcopenia have poor functional outcomes, and many require long-term care after surgery. We hypothesized that the SI can predict preoperative and early postoperative functional outcomes. Preoperative serum creatinine and cystatin C were measured to calculate the SI for patients with surgically treated HF (n = 130, mean age: 87.8 ± 6.9 years). Walking ability before and 2 weeks after surgery was assessed, and patients were dichotomized into independent and assistance groups. To assess the validity of the SI, we examined its correlation with the quality [computed tomography (CT) value] and quantity (cross-sectional area) of the muscles around the hip on the non-operated side, which were preoperatively measured using CT. Receiver operating characteristic (ROC) analysis was performed to evaluate the prognostic value of the SI. The SI of the preoperative independent (n = 77) and assistance groups (n = 53) significantly differed (70.2 ± 12.4 and 60.1 ± 9.8, respectively, P < 0.000001). At 2 weeks after surgery, the SI was significantly higher in the independent group (n = 31, 73.0 ± 14.9) than in the assistance group (n = 99, 64.0 ± 10.7, P = 0.0003). In the preoperative independent group, 28 could walk independently after surgery (SI: 74.8 ± 14.0) while 49 required assistance (SI: 67.7 ± 10.6, P = 0.01). For patients with femoral neck fracture (FNF), the SIs were significantly higher in the postoperative independent group (78.6 ± 15.7) than in the postoperative assistance group (63.2 ± 10.9, P = 0.002). Logistic regression analysis showed that the odds ratio (95% confidence interval) of the SI for postoperative walking ability was 0.95 (0.91-0.99, P = 0.03). The correlations of SIs with CT values and cross-sectional areas were as follows: iliopsoas at the apex of the femoral head, r = 0.40, P < 0.001 and r = 0.49, P < 0.001, respectively; rectus femoris at the level of the lessor trochanter, r = 0.26, P = 0.007 and r = 0.37, P < 0.001, respectively. ROC analysis for predicting postoperative walking ability in preoperative independent patients with HF and FNF revealed areas under the curve (95% confidence interval) of 0.63 (0.50-0.76) and 0.80 (0.65-0.96), respectively. In patients with HF, the SI correlated with preoperative walking ability and could predict postoperative walking ability. Among patients who could walk independently before surgery, those with high SIs could walk independently early in the postoperative period. The SI is beneficial for estimating walking ability in patients with HF.

Sections du résumé

BACKGROUND
The sarcopenia index (SI), calculated as the ratio of serum creatinine to cystatin C levels, reflects skeletal muscle mass and strength. Patients with hip fracture (HF) and sarcopenia have poor functional outcomes, and many require long-term care after surgery. We hypothesized that the SI can predict preoperative and early postoperative functional outcomes.
METHODS
Preoperative serum creatinine and cystatin C were measured to calculate the SI for patients with surgically treated HF (n = 130, mean age: 87.8 ± 6.9 years). Walking ability before and 2 weeks after surgery was assessed, and patients were dichotomized into independent and assistance groups. To assess the validity of the SI, we examined its correlation with the quality [computed tomography (CT) value] and quantity (cross-sectional area) of the muscles around the hip on the non-operated side, which were preoperatively measured using CT. Receiver operating characteristic (ROC) analysis was performed to evaluate the prognostic value of the SI.
RESULTS
The SI of the preoperative independent (n = 77) and assistance groups (n = 53) significantly differed (70.2 ± 12.4 and 60.1 ± 9.8, respectively, P < 0.000001). At 2 weeks after surgery, the SI was significantly higher in the independent group (n = 31, 73.0 ± 14.9) than in the assistance group (n = 99, 64.0 ± 10.7, P = 0.0003). In the preoperative independent group, 28 could walk independently after surgery (SI: 74.8 ± 14.0) while 49 required assistance (SI: 67.7 ± 10.6, P = 0.01). For patients with femoral neck fracture (FNF), the SIs were significantly higher in the postoperative independent group (78.6 ± 15.7) than in the postoperative assistance group (63.2 ± 10.9, P = 0.002). Logistic regression analysis showed that the odds ratio (95% confidence interval) of the SI for postoperative walking ability was 0.95 (0.91-0.99, P = 0.03). The correlations of SIs with CT values and cross-sectional areas were as follows: iliopsoas at the apex of the femoral head, r = 0.40, P < 0.001 and r = 0.49, P < 0.001, respectively; rectus femoris at the level of the lessor trochanter, r = 0.26, P = 0.007 and r = 0.37, P < 0.001, respectively. ROC analysis for predicting postoperative walking ability in preoperative independent patients with HF and FNF revealed areas under the curve (95% confidence interval) of 0.63 (0.50-0.76) and 0.80 (0.65-0.96), respectively.
CONCLUSIONS
In patients with HF, the SI correlated with preoperative walking ability and could predict postoperative walking ability. Among patients who could walk independently before surgery, those with high SIs could walk independently early in the postoperative period. The SI is beneficial for estimating walking ability in patients with HF.

Identifiants

pubmed: 35170256
doi: 10.1002/jcsm.12940
pmc: PMC8977951
doi:

Substances chimiques

Cystatin C 0
Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

945-954

Informations de copyright

© 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.

Références

J Formos Med Assoc. 2020 Dec;119(12):1807-1816
pubmed: 32107098
Endocr J. 2020 Jul 28;67(7):733-740
pubmed: 32213726
Diabetes Res Clin Pract. 2018 May;139:52-58
pubmed: 29496508
J Bone Metab. 2016 Nov;23(4):215-221
pubmed: 27965943
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Acta Orthop. 2020 Feb;91(1):58-62
pubmed: 31635502
Epidemiol Rev. 2013;35:51-65
pubmed: 23221972
Clin Nutr. 2021 Jun;40(6):4360-4365
pubmed: 33516603
Bone. 2021 Feb;143:115567
pubmed: 32745690
Int Urol Nephrol. 2019 Jan;51(1):79-83
pubmed: 30361963
Clin Orthop Relat Res. 1994 May;(302):75-82
pubmed: 8168326
Orthopedics. 2018 Nov 1;41(6):e789-e796
pubmed: 30222797
J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):338-346
pubmed: 30784237
Eur J Intern Med. 2021 Feb;84:74-79
pubmed: 32718879
Biomed Rep. 2020 Mar;12(3):89-98
pubmed: 32042417
Scand J Clin Lab Invest. 2021 May;81(3):201-207
pubmed: 33606570
AJR Am J Roentgenol. 2017 Jun;208(6):W208-W215
pubmed: 28267356
J Am Med Dir Assoc. 2015 Mar;16(3):247-52
pubmed: 25548028
BMJ. 2002 Oct 19;325(7369):868-9
pubmed: 12386038
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2259-2261
pubmed: 34904399
Age Ageing. 2014 Jul;43(4):464-71
pubmed: 24895018
Osteoporos Int. 1997;7(5):407-13
pubmed: 9425497
Osteoporos Int. 1992 Nov;2(6):285-9
pubmed: 1421796
Colorectal Dis. 2019 May;21(5):538-547
pubmed: 30648340
J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):945-954
pubmed: 35170256
BMJ Open Diabetes Res Care. 2021 Nov;9(2):
pubmed: 34732398
Skeletal Radiol. 2020 Oct;49(10):1649-1655
pubmed: 32476068
Clin Nutr. 2020 Aug;39(8):2435-2441
pubmed: 31732290
Sci Rep. 2020 Jan 27;10(1):1260
pubmed: 31988356
J Bone Miner Metab. 2019 Sep;37(5):871-879
pubmed: 30623251
Lancet. 2002 May 18;359(9319):1761-7
pubmed: 12049882
PLoS One. 2019 Aug 1;14(8):e0213223
pubmed: 31369561
Clin Orthop Relat Res. 1993 Jul;(292):215-22
pubmed: 8519112
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
J Orthop Sci. 2017 Sep;22(5):909-914
pubmed: 28728988
Injury. 2021 Jun;52(6):1456-1461
pubmed: 33279172
Hepatol Res. 2020 Jun;50(6):704-714
pubmed: 32061107
Geriatr Gerontol Int. 2016 Sep;16(9):1021-7
pubmed: 26338368
Clin Physiol Funct Imaging. 2020 May;40(3):165-172
pubmed: 31913561
Clin Orthop Relat Res. 2013 Aug;471(8):2703-10
pubmed: 23546850
Medicine (Baltimore). 2017 Oct;96(42):e8278
pubmed: 29049224
J Orthop Trauma. 2012 Mar;26(3):163-71
pubmed: 21918484
Clin Nutr. 2021 Mar;40(3):1274-1280
pubmed: 32863062
J Clin Med. 2018 Oct 10;7(10):
pubmed: 30308959
Crit Care Med. 2017 Jan;45(1):e23-e29
pubmed: 27611976
BMC Musculoskelet Disord. 2019 Nov 27;20(1):568
pubmed: 31775693

Auteurs

Naoki Okubo (N)

Department of Orthopedic Surgery, North Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Orthopedics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Takashi Yoshida (T)

Department of Orthopedic Surgery, North Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Kazuya Tanaka (K)

Department of Orthopedic Surgery, North Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Naoya Okada (N)

Department of Orthopedic Surgery, North Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Kunihiko Hosoi (K)

Department of Orthopedic Surgery, North Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Masato Ohara (M)

Department of Orthopedic Surgery, North Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Orthopedics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Kenji Takahashi (K)

Department of Orthopedics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH